Methylgene's IPO

Methylgene raised a round of funding on June 29, 2004. Investors include Public.

TSE: MYG Biopharmaceutical company focused on the discovery, development and commercialization of novel enzyme inhibitors for the treatment of cancer and infectious diseases. The company uses function…

Articles about Methylgene's IPO: